| Rushir Choksi, MD | |
|
129 Oneida Valley Rd Ste 311, Butler, PA 16001-2252 | |
| (724) 482-2717 | |
| (724) 482-2769 |
| Full Name | Rushir Choksi |
|---|---|
| Gender | Male |
| Speciality | Medical Oncology |
| Experience | 18 Years |
| Location | 129 Oneida Valley Rd Ste 311, Butler, Pennsylvania |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1851553663 | NPI | - | NPPES |
| 005490300 | Medicaid | FL |
| Facility Name | Location | Facility Type |
|---|---|---|
| Butler Memorial Hospital | Butler, PA | Hospital |
| Upmc Passavant | Pittsburgh, PA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Butler Cancer Associates Inc | 7719122316 | 10 |
| Oncology Hematology Association Inc | 9830003300 | 163 |
News Archive
Columbia University Medical Center researchers have pinpointed the immune system mechanism that allows a kidney transplant to be accepted without lifelong immunosuppressive drugs, a significant step toward reducing or eliminating the need for costly and potentially toxic immunosuppressant drugs and improving long-term transplant success.
Earlier this year, scientists discovered that a variant of the TCF7L2 gene was associated with type 2 diabetes. In subsequent media coverage, they claimed this could lead to a diagnostic test to identify people who carry the variant gene and that people who knew of their extra risk would then be motivated to avoid the lifestyle habits that lead to diabetes.
As the increasing number food scares causes consumers to question the safety of everyday food items, researchers at Queen's University Belfast have completed the first ever analysis of all the food recalls announced in the USA, UK and Ireland over the last decade.
Currently, prenatal diagnosis of genetic diseases and genetic monitoring of fetal development require invasive procedures.
LecTec Corporation (OTCBB: LECT) announced today that it has reached a settlement with Endo Pharmaceuticals Inc. on outstanding patent litigation related to LecTec's U.S. Patent Nos. 5,536,263 and 5,741,510. Endo Pharmaceuticals has agreed to make a one–time, $23 million payment for the exclusive license to these two patents for use in the field of prescription pain medicines and treatment.
› Verified 5 days ago
| Entity Name | Oncology Hematology Association Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1861469223 PECOS PAC ID: 9830003300 Enrollment ID: O20031118000757 |
News Archive
Columbia University Medical Center researchers have pinpointed the immune system mechanism that allows a kidney transplant to be accepted without lifelong immunosuppressive drugs, a significant step toward reducing or eliminating the need for costly and potentially toxic immunosuppressant drugs and improving long-term transplant success.
Earlier this year, scientists discovered that a variant of the TCF7L2 gene was associated with type 2 diabetes. In subsequent media coverage, they claimed this could lead to a diagnostic test to identify people who carry the variant gene and that people who knew of their extra risk would then be motivated to avoid the lifestyle habits that lead to diabetes.
As the increasing number food scares causes consumers to question the safety of everyday food items, researchers at Queen's University Belfast have completed the first ever analysis of all the food recalls announced in the USA, UK and Ireland over the last decade.
Currently, prenatal diagnosis of genetic diseases and genetic monitoring of fetal development require invasive procedures.
LecTec Corporation (OTCBB: LECT) announced today that it has reached a settlement with Endo Pharmaceuticals Inc. on outstanding patent litigation related to LecTec's U.S. Patent Nos. 5,536,263 and 5,741,510. Endo Pharmaceuticals has agreed to make a one–time, $23 million payment for the exclusive license to these two patents for use in the field of prescription pain medicines and treatment.
› Verified 5 days ago
| Entity Name | Butler Cancer Associates Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1649519778 PECOS PAC ID: 7719122316 Enrollment ID: O20130403000115 |
News Archive
Columbia University Medical Center researchers have pinpointed the immune system mechanism that allows a kidney transplant to be accepted without lifelong immunosuppressive drugs, a significant step toward reducing or eliminating the need for costly and potentially toxic immunosuppressant drugs and improving long-term transplant success.
Earlier this year, scientists discovered that a variant of the TCF7L2 gene was associated with type 2 diabetes. In subsequent media coverage, they claimed this could lead to a diagnostic test to identify people who carry the variant gene and that people who knew of their extra risk would then be motivated to avoid the lifestyle habits that lead to diabetes.
As the increasing number food scares causes consumers to question the safety of everyday food items, researchers at Queen's University Belfast have completed the first ever analysis of all the food recalls announced in the USA, UK and Ireland over the last decade.
Currently, prenatal diagnosis of genetic diseases and genetic monitoring of fetal development require invasive procedures.
LecTec Corporation (OTCBB: LECT) announced today that it has reached a settlement with Endo Pharmaceuticals Inc. on outstanding patent litigation related to LecTec's U.S. Patent Nos. 5,536,263 and 5,741,510. Endo Pharmaceuticals has agreed to make a one–time, $23 million payment for the exclusive license to these two patents for use in the field of prescription pain medicines and treatment.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Rushir Choksi, MD 129 Oneida Valley Rd Ste 311, Butler, PA 16001-2252 Ph: (724) 482-2717 | Rushir Choksi, MD 129 Oneida Valley Rd Ste 311, Butler, PA 16001-2252 Ph: (724) 482-2717 |
News Archive
Columbia University Medical Center researchers have pinpointed the immune system mechanism that allows a kidney transplant to be accepted without lifelong immunosuppressive drugs, a significant step toward reducing or eliminating the need for costly and potentially toxic immunosuppressant drugs and improving long-term transplant success.
Earlier this year, scientists discovered that a variant of the TCF7L2 gene was associated with type 2 diabetes. In subsequent media coverage, they claimed this could lead to a diagnostic test to identify people who carry the variant gene and that people who knew of their extra risk would then be motivated to avoid the lifestyle habits that lead to diabetes.
As the increasing number food scares causes consumers to question the safety of everyday food items, researchers at Queen's University Belfast have completed the first ever analysis of all the food recalls announced in the USA, UK and Ireland over the last decade.
Currently, prenatal diagnosis of genetic diseases and genetic monitoring of fetal development require invasive procedures.
LecTec Corporation (OTCBB: LECT) announced today that it has reached a settlement with Endo Pharmaceuticals Inc. on outstanding patent litigation related to LecTec's U.S. Patent Nos. 5,536,263 and 5,741,510. Endo Pharmaceuticals has agreed to make a one–time, $23 million payment for the exclusive license to these two patents for use in the field of prescription pain medicines and treatment.
› Verified 5 days ago
Uzma Shahzad, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 1 Hospital Way, Butler, PA 16001 Phone: 724-284-4309 Fax: 724-284-7464 | |
Sanjeev Suri, M.D Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 202 W Diamond St, Butler, PA 16001 Phone: 724-431-0253 Fax: 724-431-0254 | |
Dr. Donald Arthur Walters, D.O. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 104 Technology Dr, Suite 202, Butler, PA 16001 Phone: 724-482-6062 Fax: 724-482-6117 | |
John Reefer, M.D. Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 480 E Jefferson St, 2nd Floor, Suite B, Butler, PA 16001 Phone: 727-285-0870 Fax: 724-283-3887 | |
Dr. Thomas B. Pinto, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 127 Onelda Valley Rd, Suite 202, Butler, PA 16001 Phone: 866-620-6761 Fax: 724-283-3043 | |
Dr. Stephanie L Clark, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 1 Hospital Way, Butler, PA 16001 Phone: 724-285-0823 Fax: 724-285-0879 | |
Dr. Jessica Marie Buriak, D.O. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 480 E Jefferson St, Butler, PA 16001 Phone: 724-431-0633 Fax: 724-431-0428 |